Corbus Pharma (CRBP) Reports Q2 Loss of $0.11/Share

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($0.11), versus ($0.10) reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• UBS Reiterates Buy Rating on Dollar Tree (DLTR)
• Goldman Sachs reports global fund inflows for week of July 8